CannAmerica Brands Corp. (CNNXF) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 18, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerCannAmerica Brands Corp. (CNNXF) trades at $0.00001. CannAmerica Brands Corp. operates in the cannabis industry, focusing on brand development and licensing. The company's products include cannabis-infused gummies, vape pens, and concentrates, distributed across multiple states. Sector: Healthcare.
Price as of · Last analyzed: Mar 18, 2026Analyst Coverage for CNNXF: CNNXF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
CannAmerica Brands Corp. (CNNXF) Healthcare & Pipeline Overview
CannAmerica Brands Corp. is a cannabis brand and licensing company, offering products such as gummies and vape pens across Colorado, Nevada, Oklahoma, and Massachusetts. It focuses on building brand value through marketing and distribution partnerships in the competitive cannabis market, facing evolving regulations and consumer preferences.
What Is the Investment Thesis for CNNXF?
CannAmerica Brands Corp. presents a speculative investment opportunity within the evolving cannabis market. The company's focus on brand licensing offers a scalable business model, but its negative profit margin of -918.8% indicates significant challenges in achieving profitability. Key value drivers include successful brand development, expansion into new markets, and effective marketing strategies. Growth catalysts include regulatory changes favoring cannabis legalization and increasing consumer acceptance of cannabis products. Potential risks include intense competition, fluctuating cannabis prices, and evolving regulatory landscapes. Investors should closely monitor the company's financial performance, market expansion efforts, and ability to navigate regulatory hurdles. The company's negative beta of -0.60 suggests low correlation with the broader market.
Based on FMP financials and quantitative analysis
CNNXF Key Highlights
CannAmerica Brands Corp. operates with a focus on brand licensing within the cannabis industry.
- The company's gross margin stands at 85.0%, indicating strong potential for profitability if operational costs are managed effectively.
- CannAmerica's product line includes cannabis-infused gummies, vape pens, and concentrates, targeting both medical and recreational users.
- The company's market capitalization is $0.00B, reflecting its current stage of development and market perception.
- CannAmerica distributes its products through dispensaries, wholesalers, and distributors in Colorado, Nevada, Oklahoma, and Massachusetts.
Who Are CNNXF's Competitors?
CNNXF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| MEDS TRxADE HEALTH, Inc. | $3.68 | -9.36% | $9.65M | — |
| MSLE Satellos Bioscience Inc. Common Stock | $8.50 | -0.12% | $11.0M | — |
| NEUP Neuphoria Therapeutics Inc. | $3.47 | -1.14% | $18.8M | — |
| AIXC AIxCrypto Holdings, Inc. | $1.01 | -39.16% | $20.4M | — |
| RNTX Rein Therapeutics, Inc. | $0.80 | -6.03% | $22.4M | — |
| KYNB Kyntra Bio, Inc. | $6.31 | -2.92% | $25.5M | — |
| YI 111, Inc. | $3.22 | -2.57% | $28.1M | — |
| PETS PetMed Express, Inc. | $1.36 | -0.73% | $29.1M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CNNXF's Key Strengths?
Established brand portfolio.
- Distribution network in multiple states.
- Diverse product offerings.
- High gross margin (85.0%).
What Are CNNXF's Weaknesses?
Negative profit margin (-918.8%).
- Limited market capitalization.
- Reliance on third-party distributors.
- Exposure to regulatory risks.
What Are the Key Risks for CNNXF?
Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.
- Intense competition in the cannabis industry is putting pressure on prices and margins.
- Fluctuating cannabis prices could impact revenue and profitability.
- Evolving regulatory landscape creates uncertainty and compliance challenges.
- Potential for increased taxation on cannabis products.
- Limited access to capital due to the stigma associated with the cannabis industry.
What Are CNNXF's Competitive Advantages?
- Brand recognition in select markets.
- Established distribution network in Colorado, Nevada, Oklahoma, and Massachusetts.
- Proprietary product formulations.
- Licensing agreements provide recurring revenue.
What Does CNNXF Do?
CannAmerica Brands Corp. was founded with the objective of creating and promoting a portfolio of cannabis brands in the burgeoning medical and recreational cannabis market. The company operates by developing its brands and then licensing them to various distributors, wholesalers, and dispensaries. This strategy allows CannAmerica to focus on brand development and marketing, while leveraging the existing infrastructure of its partners for production and distribution. CannAmerica's product line includes cannabis-infused gummy products, disposable vape pens, distillate droppers, and shatter and wax concentrate products, all marketed under the CannAmerica brand. The company's geographic footprint currently extends to Colorado, Nevada, Oklahoma, and Massachusetts, with potential for further expansion as regulations evolve and new markets open up. CannAmerica aims to establish a strong brand presence and capture market share in the competitive cannabis industry through strategic partnerships and product innovation. The company is headquartered in Vancouver, Canada.
What Products and Services Does CNNXF Offer?
- Owns a portfolio of cannabis brands.
- Licenses its brands to distributors and dispensaries.
- Markets and promotes its brands to consumers.
- Offers cannabis-infused gummy products.
- Provides disposable vape pens.
- Sells distillate droppers.
- Offers shatter and wax concentrate products.
How Does CNNXF Make Money?
- Develops and owns cannabis brands.
- Licenses brands to third-party manufacturers and distributors.
- Generates revenue through licensing fees and royalties.
- Focuses on marketing and brand promotion.
What Industry Does CNNXF Operate In?
CannAmerica Brands Corp. operates in the rapidly growing cannabis industry, which is characterized by evolving regulations, increasing consumer demand, and intense competition. The market includes both medical and recreational cannabis products, with various companies vying for market share. CannAmerica's focus on brand licensing positions it within a segment that requires strong marketing and distribution partnerships. The industry is subject to changing legal frameworks and consumer preferences, requiring companies to adapt quickly. Competitors range from large, established cannabis companies to smaller, niche brands.
Who Are CNNXF's Key Customers?
- Cannabis dispensaries.
- Wholesalers and distributors of cannabis products.
- Medical cannabis patients.
- Recreational cannabis users.
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Key Financial Metrics
Return on equity for CannAmerica Brands Corp. stands at 103.7%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.05 means current liabilities exceed short-term assets, a liquidity point worth watching.
Company Profile
CannAmerica Brands Corp. operates in the Healthcare sector. It is headquartered in Vancouver, CA. CNNXF has traded publicly since 2018.
Financial Health
CannAmerica Brands Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny.
CNNXF Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
CNNXF Latest News
-
Ensysce Biosciences (NASDAQ:ENSC) versus CannAmerica Brands (OTCMKTS:CNNXF) Head to Head Review
defenseworld.net · Aug 13, 2026
CNNXF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for CNNXF.
Price Targets
Wall Street price target analysis for CNNXF.
CNNXF MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for CNNXF; grades run from A+ (80-100) to F (below 30).
Leadership: Diana Anglin
CEO
Diana Anglin serves as the CEO of CannAmerica Brands Corp. Her background includes experience in business development, marketing, and operations within the cannabis industry. She has been involved in various aspects of the cannabis sector, from cultivation and processing to retail and brand management. Anglin's expertise lies in building and scaling cannabis businesses, navigating regulatory complexities, and developing effective marketing strategies.
Track Record: Under Diana Anglin's leadership, CannAmerica Brands Corp. has focused on expanding its brand portfolio and distribution network. Key milestones include establishing partnerships with distributors in multiple states and launching new cannabis products. Anglin has also overseen the company's efforts to comply with evolving cannabis regulations and adapt to changing market conditions. Her strategic decisions have aimed to position CannAmerica for growth in the competitive cannabis industry.
CNNXF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that CannAmerica Brands Corp. may not meet the minimum financial or disclosure requirements for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory scrutiny as those listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries higher risks due to the potential for limited information and liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure.
- Low trading volume and liquidity.
- Potential for price manipulation.
- Higher risk of fraud or mismanagement.
- Limited regulatory oversight.
- Verify the availability and accuracy of financial statements.
- Assess the company's management team and their track record.
- Research the company's business model and competitive landscape.
- Evaluate the company's compliance with regulatory requirements.
- Monitor trading volume and price volatility.
- Consult with a financial advisor.
- Understand the risks associated with OTC investments.
- Established brand portfolio.
- Distribution network in multiple states.
- High gross margin (85.0%).
- CEO with industry experience.
- Operation in regulated cannabis markets.
CannAmerica Brands Corp. Healthcare Stock: Key Questions Answered
What does CannAmerica Brands Corp. do?
CannAmerica Brands Corp. operates as a brand and licensing company within the cannabis industry. It develops and owns a portfolio of cannabis brands, which it then licenses to third-party manufacturers, distributors, and dispensaries. The company generates revenue through licensing fees and royalties, focusing on marketing and brand promotion to drive demand for its products.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- Financial data may be limited due to the company's OTC listing.